Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an anticholinergic medication that acts primarily on the smooth muscle of the gastrointestinal and genitourinary tracts. It is a quaternary ammonium compound, which limits its systemic absorption and ability to cross the blood-brain barrier, thereby reducing central anticholinergic side effects compared to tertiary amine anticholinergics.
## Primary Indications
* Symptomatic relief of abdominal cramping and pain associated with gastrointestinal spasms, such as irritable bowel syndrome (IBS).
* Pre-procedural bowel preparation to reduce spasm.
## Adult Dosing
* **Oral:** 10 mg to 20 mg three to five times daily. Maximum dose not clearly established, but typically not to exceed 100 mg/day.
* **Intramuscular/Intravenous:** 20 mg every 6 to 8 hours as needed. Higher doses may be used in acute settings under medical supervision, but specific maximums are not universally defined.
## Pediatric Dosing
Dosing in children is less well-established and often requires caution.
* **Oral:** 10 mg three times daily for children over 6 years of age. Dosing for younger children is generally not recommended or should be guided by specialist advice.
* **Intramuscular/Intravenous:** Not typically recommended for children under 12 years of age due to limited safety data and increased risk of adverse effects. If used, it should be under strict medical supervision.
## Dose Adjustments
No dose adjustments are typically required for hepatic or renal impairment, given the limited systemic absorption and metabolism of hyoscine butylbromide.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Myasthenia gravis.
* Untreated narrow-angle glaucoma.
* Tachyarrhythmias.
* Ileus or bowel obstruction.
* Megacolon.
* Prostatic hypertrophy with urinary retention.
## Adverse Effects
Common adverse effects are generally mild and related to anticholinergic activity:
* Dry mouth
* Tachycardia
* Constipation
* Urinary retention
* Blurred vision
* Sweating may be reduced
Less common but serious effects include:
* Anaphylactic reactions
* Acute angle-closure glaucoma
* Drowsiness (rare due to limited CNS penetration)
## Key Drug Interactions
* **Increased anticholinergic effects:** Additive effects with other anticholinergic medications (e.g., tricyclic antidepressants, antihistamines, antiparkinsonian drugs, other antispasmodics).
* **Prokinetic agents:** May antagonize the effects of prokinetic agents.
* **Dopamine antagonists:** May reduce the efficacy of dopamine antagonists (e.g., metoclopramide).
## Monitoring
* Monitor for relief of abdominal symptoms.
* Observe for anticholinergic side effects, especially in the elderly or those with pre-existing conditions (e.g., urinary retention, glaucoma).
* Assess for signs of hypersensitivity reactions.
## Clinical Pearls
* Hyoscine butylbromide is a peripheral-acting anticholinergic, making it a preferred choice for GI spasms when central effects are undesirable.
* Intravenous administration provides rapid onset of action for acute severe pain.
* Ensure proper patient education regarding potential side effects, especially dry mouth and blurred vision.
* Use with caution in patients with conditions that could be exacerbated by anticholinergic effects.
---
*This information is intended for clinical pharmacists and should not be a substitute for professional medical advice. Always consult the most current prescribing information and local protocols before administering any medication.*
